Ashwagandha
Ashwagandha has been studied in 332 papers since 1992: 76 trials and 2 observational studies in people, 56 in animals, 51 in cells, 110 reviews; 55 in the past year. Its furthest trials in people are at phase 2. The newest paper, Nov 11, 2026: “Effects on Sleep Quality and Bioelectrical Parameters of Cellular Health After Administration of a Plant…”.
InterventionPhase 2Withania somnifera
332 papers study it7 more mention it233 findingsUpdated
Part of Bryan Johnson's BlueprintMore supplements
3 new papers in 30 daysSee all 106 papers on ashwagandha
At a glance
Independent labs found the same change in people. 47 independent labs in 15 countries; 7 trials, none about aging, 2 with no results posted.
“Overall, both Ashwagandha and melatonin improved sleep disturbances in adults, with combination therapy producing the most consistent and pronounced benefits.”
17 of its findings point the other way.
- 47 independent labs in 15 countries
- 17 findings against
- 7 trials, none about aging, 2 with no results posted
- Funders: Natreon and others
- 45 of 205 findings with company ties
- 1 of 7 trials sponsored by its developers
- Human trial42
- Humans1
- Animals5
- Model organisms3
- Cells2
Studies in people
See all 37 studies of ashwagandha in people37 studies gave ashwagandha to people and measured what changed.
| What changed | Design | People | Source |
|---|---|---|---|
up: Improves sleep qualitymean change -5.2 vs. -0.8 down: Decreases menopausal symptomsmean change -8.1 vs. -1.2 down: Decreases body fat percentagemean change -0.6% vs. +0.03% | Randomized trial12 weeks | 66 peopleWomen45-65 yearsPostmenopausal women; Midlife adults; Older adults; postmenopausal women | Menopause (New York, N.Y.), Sep 15, 2026 |
| Randomized trialeight weeks | 200 peopleBothaged 18 to 50 yearsAdults aged 18 to 50 years who met the DSM-5 diagnostic criteria for sleep disturbance | Clocks & sleep, Mar 27, 2026 | |
down: Decreases cortisol7.83 ± 2.61 vs 6.33 ± 2.01 mg/dL | Randomized trial60 days | 135 people53.17% were male34.79 ± 8.16 years | Medicine, Mar 13, 2026 |
up: Improves Older People Quality of Life Questionnairep < 0.0001 up: Improves Epworth Sleepiness Scalep < 0.001 up: Improves Senior Fitness Testp < 0.01 | Randomized trial8 weeks | 50 peopleBothbetween 60 and 85 yearsOlder adults | Phytotherapy research : PTR, Feb 22, 2026 |
down: Decreases perceived stress up: Improves sleep quality down: Decreases anxiety | Randomized trial60 days | 186 peoplepredominantly female (67%)mean age of 37 yearsHighly stressed individuals with a PSS score in the range of 27–40 and an RSQ-W score of ≤ 50 | Trials, Feb 9, 2026 |
What did studies of ashwagandha find?
99Studies of ashwagandha measured 99 outcomes; the most studied are sleep quality (13 studies), cognitive function (12) and cortisol (11).
Sleep quality
upin humans12upin reviews1
13 studies
Sleep quality
upin humans12upin reviews1
Ashwagandha improves sleep quality in humans (postmenopausal women) (mean change -5.2 vs. -0.8).
“ashwagandha group demonstrated significantly greater improvements in sleep quality (mean change -5.2 vs. -0.8; P<0.001)”
Human trialpostmenopausal womenroot extract600 mg/day12 weeksfemalesn = 66
Menopause (New York, N.Y.)
Ashwagandha improves sleep quality in humans.
“Compared to group C, PSQI global score significantly reduced as early as day 7 in group A and group B.”
Human trial60 daysn = 135
Medicine
Ashwagandha improves sleep quality in humans.
“Additionally, the global PSQI score results were also statistically significant in the IP arms when compared to placebo (VL-G-A57: p = 0.0008, VL-G-E12: p < 0.0001).”
Human trial60 daysn = 186
Trials
Ashwagandha improves sleep quality in humans (p < 0.0001).
“Sleep quality, as measured by the Pittsburgh Sleep Quality Index (PSQI), improved significantly in both adaptogen groups (VL-G-A57: p = 0.0008, VL-G-E12: p < 0.0001).”
Human trial60 days
Trials
Ashwagandha improves sleep quality in humans (− 3.0 ± 0.2 for ZEN vs. 0.1 ± 0.3 for placebo, p < 0.05).
“The between-group analysis showed a statistically significant (p < 0.05) decrease in global PSQI score in the ZEN group compared to the placebo group on days 28 (− 1.4 ± 0.2 for ZEN vs. − 0.6 ± 0.1 for placebo), 56 (− 2.6 ± 0.2 for ZEN vs. -0.7 ± 0.3 for placebo), and 84 (− 3.0 ± 0.2 for ZEN vs. 0.1 ± 0.3 for placebo”
Human trial84 daysn = 90
Advances in therapy
Ashwagandha improves sleep quality in human subjects with non-chronic mild to moderate stress.
“ZEN 125 mg showed significant (p < 0.05) improvements in PSS, BAI, and PSQI scores on days 28, 56, and 84”
Human trialin human subjects with non-chronic mild to moderate stress125 mg84 days
Advances in therapy
Ashwagandha improves sleep quality in humans.
“Additionally, analysis using ANOVA demonstrated a significant change between groups for perceived sleep quality in ASH compared to PLA (p = 0.038), with scores depicted in Figure.”
Human trial28 daysfemalesn = 30
European journal of sport science
Ashwagandha improves sleep quality in humans (FAST frailty score ≥7; assessed by PSQI; compared with placebo).
“Significant improvement (p<0.01) in scores for FAST, 6MWTs, PSQI, MMSE, and SF-12 were seen with ARE after 8 weeks.”
Human trialFAST frailty score ≥7; assessed by PSQI; compared with placeboroot extract capsule600 mg/day8 weeksn = 50
medRxivPreprint
Ashwagandha improves sleep quality in humans (stressed subjects) (PSQI score p < .0001; OHQ score p < .0001).
“significantly better psychological well-being and sleep quality in the former”
Human trialstressed subjectssustained-release capsule300 mg90 daysn = 125
Evidence-based complementary and alternative medicine : eCAM
Ashwagandha improves sleep quality in humans (healthy and insomnia subjects).
“In both healthy and insomnia subjects, there was a significant improvement in the sleep parameters in the Ashwagandha root extract supplemented group.”
Human trialhealthy and insomnia subjects8-weeksn = 80
Journal of ethnopharmacology
All 16Fewer
Cognitive function
upin humans11upin reviews1
12 studies
Cognitive function
upin humans11upin reviews1
Ashwagandha improves cognitive function in humans (mild cognitive impairment).
“Within Control Group, statistically highly significant results in the score of MoCA Scale.”
Human trialmild cognitive impairment30 daysn = 15
Journal of Ayurveda and Integrated Medical Sciences
Ashwagandha improves cognitive function in humans (mild cognitive impairment) (+14.77% at 60 days).
“Significant improvement was observed with Somin-OnTM in memory assessment scales viz. MoCA (7.83% at 30 days and 14.77% at 60 days, from baseline) and MMSE”
Human trialmild cognitive impairmentstandardized with Sominone250 mg daily60 daysn = 40
Journal of psychopharmacology (Oxford, England)
Ashwagandha improves cognitive function in humans (self-reported cognitive and energy problems) (p < .05).
“Greater improvement (p < .05) from baseline scores were seen with ARE as against placebo for COMPASS items episodic memory, working memory and accuracy of attention.”
Human trialself-reported cognitive and energy problemsroot extract600 mg/day8 weeks
Journal of psychoactive drugs
Ashwagandha improves cognitive function in humans (FAST frailty score ≥7; assessed by MMSE; compared with placebo).
“Significant improvement (p<0.01) in scores for FAST, 6MWTs, PSQI, MMSE, and SF-12 were seen with ARE after 8 weeks.”
Human trialFAST frailty score ≥7; assessed by MMSE; compared with placeboroot extract capsule600 mg/day8 weeksn = 50
medRxivPreprint
Ashwagandha improves cognitive function in humans.
“The percentage correct response increased from 86.92 ± 18.71 to 96.92 ± 7.36, P =.006 in ARE and from 93.08 ± 9.70 to 92.31 ± 9.92, P =.83 in the placebo, the change being significantly better (P =.02) in ARE group compared to placebo.”
Human trialcapsule60 daysn = 50
Medicine
Ashwagandha improves cognitive function in humans (400 mg/day vs placebo).
“A pair-wise comparison showed a significant difference in the scores for reaction time when the placebo group was compared to the Ashwaghanda 400 mg/day group, as scores were significantly lower in the latter group.”
Human trial400 mg/day vs placebo30 days
Efficacy of Withania somnifera supplementation on adult's cognition and mood
Journal of Ayurveda and integrative medicine
Ashwagandha improves cognitive function in humans (mild cognitive impairment).
“The treatment group also demonstrated significantly greater improvement in executive function, sustained attention, and information-processing speed”
Human trialmild cognitive impairmentroot extract300 mg twice daily8 weeks
Journal of dietary supplements
Ashwagandha improves cognitive function in RCTs of healthy individuals and patients with stress-related or functional disorders.
“enhancement of cognitive functions, increased muscle strength and recovery, and favourable hormonal changes.”
Reviewin RCTs of healthy individuals and patients with stress-related or functional disorders120-1000 mg daily for W. somnifera, 290-1500 mg daily for R. rosea3-16 weeks
Annals of agricultural and environmental medicine : AAEM
Ashwagandha improves cognitive function in humans (mild cognitive impairment).
“trials have consistently shown its ability to improve cognitive function, including memory and information-processing speed, particularly in adults with mild cognitive impairment”
Reviewmild cognitive impairment
Biogerontology
Ashwagandha improves cognitive function in animal models.
“It improves cognition and reverses induced cognitive deficits.”
Reviewin animal models
Potential clinical applications of Ashwagandha (Withania somnifera) in medicine and neuropsychiatry
Expert review of clinical pharmacology
All 12Fewer
Cortisol
downin humans8no changein humans3downin reviews1−7.8%
11 studies
Cortisol
downin humans8no changein humans3downin reviews1−7.8%
Ashwagandha decreases cortisol in humans (7.83 ± 2.61 vs 6.33 ± 2.01 mg/dL).
“Compared to baseline, at day 60 serum cortisol levels (mg/dL) in group B were reduced significantly (7.83 ± 2.61 vs 6.33 ± 2.01; P <.05); whereas, these were reduced numerically in group A (7.96 ± 2.88 vs 7.05 ± 2.46; P =.212) and group C (7.05 ± 2.74 vs 6.63 ± 2.17; P =.562).”
Human trial60 days
Medicine
Ashwagandha decreases cortisol in humans (healthy adult, stressed subjects).
“Serum cortisol levels in group B were significantly reduced on day 60 (P < .05).”
Human trialhealthy adult, stressed subjectssustained-release capsules300 mg60 daysn = 126
Medicine
Ashwagandha showed no clear effect on cortisol in humans.
“After 8 weeks, participants in the APB and ARE groups demonstrated greater reductions in serum cortisol than those in the PL group, although these differences were not statistically significant.”
Human trial8 weeksn = 130
Journal of medicine and life
Ashwagandha decreases cortisol in humans (healthy adults with moderate stress and anxiety).
“At 8 weeks, all groups have shown a significant reduction in serum cortisol”
Human trialhealthy adults with moderate stress and anxietyserum300 mg twice daily8 weeksn = 141
Journal of medicine and life
Ashwagandha showed no clear effect on cortisol in humans.
“The between-group analysis showed no significant (p < 0.05) differences between the two groups on days 56 and 84.”
Human trial84 daysn = 90
Advances in therapy
Ashwagandha decreases cortisol in humans.
“The change in morning cortisol levels from baseline to end of the study was significantly different between ARE and placebo, while the change in evening cortisol levels did not show statistical significance.”
Human trialcapsulesaliva60 daysn = 50
Medicine
Ashwagandha decreases cortisol in humans (stressed subjects) (p=0.0443).
“lower PSS-10 score (13.0 ± 5.0 vs. 18.7 ± 4.6; p < .0001), serum cortisol levels (p=0.0443)”
Human trialstressed subjectssustained-release capsule300 mg90 daysn = 125
Evidence-based complementary and alternative medicine : eCAM
Ashwagandha decreases cortisol in humans (225 mg/day).
“For cortisol levels, at Day 15 and Day 30 the Ashwagandha 225 mg/day group had significant reductions in cortisol levels compared to baseline.”
Human trial225 mg/day30 daysn = 19
Efficacy of Withania somnifera supplementation on adult's cognition and mood
Journal of Ayurveda and integrative medicine
Ashwagandha decreases cortisol in humans.
“A comparison of between-group differences revealed a statistically significant time x group interaction (F2,116 = 8.95, P = <.001).”
Human trial60-dayn = 60
Medicine
Ashwagandha decreases cortisol in humans (P < .001).
“Ashwagandha intake was also associated with greater reductions in morning cortisol (P < .001), and DHEA-S (P = .004) compared with the placebo.”
Human trialstandardized ashwagandha extract (Shoden)240 mg60-dayn = 60
Medicine
All 15Fewer
Anxiety
downin humans8upin humans1
9 studies
Anxiety
downin humans8upin humans1
Ashwagandha decreases anxiety in humans.
“The anxiety subscale scores also showed a statistically significant reduction in the IP arms at day 60 when compared to placebo (VL-G-A57: p = 0.0004, VL-G-E12: p = 0.0015).”
Human trial60 daysn = 186
Trials
Ashwagandha decreases anxiety in humans (p = 0.0015).
“anxiety (VL-G-A57: p = 0.0004, VL-G-E12: p = 0.0015)”
Human trial60 days
Trials
Ashwagandha decreases anxiety in humans.
“Improvements in the PL group were minimal, indicating the superior effectiveness of APB and ARE in reducing stress and anxiety.”
Human trial8 weeksn = 130
Journal of medicine and life
Ashwagandha decreases anxiety in humans (− 8.3 ± 0.7 for ZEN vs. 2.3 ± 0.6 for placebo, p < 0.05).
“The between-group analysis showed a statistically significant (p < 0.05) decrease in BAI score in the ZEN group compared to the placebo group on days 28 (− 3.9 ± 0.8 for ZEN vs. 0.2 ± 0.7 for placebo), 56 (− 6.2 ± 0.8 for ZEN vs. 1.5 ± 0.6 for placebo), and 84 (− 8.3 ± 0.7 for ZEN vs. 2.3 ± 0.6 for placebo”
Human trial84 daysn = 90
Advances in therapy
Ashwagandha decreases anxiety in humans (5.12 (P <.001) on day 60).
“The differences in stress scores between the groups were 2.57 (P <.05) on day 30 and 9.74 (P <.001) while the difference in anxiety scores was 1.30 and 5.12 (P <.001) on day 60.”
Human trialcapsule60 daysn = 50
Medicine
Ashwagandha decreases anxiety in humans (insomnia subjects) (p < 0.05).
“Repeat measure Analysis of variance (ANOVA) confirmed the significant improvement in SOL (p 0.013), HAM-A outcomes (p < 0.05), mental alertness (p 0.01), and sleep quality (p < 0.05) of the insomnia patients.”
Human trialinsomnia subjects8-weeksn = 40
Journal of ethnopharmacology
Ashwagandha decreases anxiety in humans.
“There was a significant decrease in the HAM-A score for the experimental group when compared with the control group.”
Human trialcapsule10 weeksn = 58
Cureus
Ashwagandha decreases anxiety in humans.
“A comparison of between-group differences revealed a statistically significant-time x group interaction (F4,232 = 2.55, P =.040).”
Human trial60-dayn = 60
Medicine
Ashwagandha decreases anxiety in humans (P = .040).
“In comparison with the placebo, ashwagandha supplementation was associated with a statistically significant reduction in the HAM-A (P = .040)”
Human trialstandardized ashwagandha extract (Shoden)240 mg60-dayn = 60
Medicine
Ashwagandha decreases anxiety in humans.
“including anxiety reduction, improved sleep quality, and enhanced sexual function”
Reviewn = 9,005
Muscles (Basel, Switzerland)
All 11Fewer
Anxiety
downin humans7
7 studies
Anxiety
downin humans7
Ashwagandha decreases anxiety in humans (healthy adults with moderate stress and anxiety).
“The proprietary herbal extract of ashwagandha root (300mg twice daily) is considered an effective and safe intervention for reducing stress and anxiety.”
Human trialhealthy adults with moderate stress and anxiety300 mg twice daily8 weeksn = 141
Journal of medicine and life
Ashwagandha decreases anxiety in human subjects with non-chronic mild to moderate stress.
“ZEN 125 mg showed significant (p < 0.05) improvements in PSS, BAI, and PSQI scores on days 28, 56, and 84”
Human trialin human subjects with non-chronic mild to moderate stress125 mg84 days
Advances in therapy
Ashwagandha decreases anxiety in humans (healthy individuals with mild to moderate symptoms).
“The PSS, GAD-7, and QOL scores improved significantly in all the participants taking ARE compared to the placebo.”
Human trialhealthy individuals with mild to moderate symptomsroot extract standardized for 2.5% withanolides500 mg ARE (12.5 mg withanolides) with 5 mg piperine once daily60 daysn = 50
Medicine
Ashwagandha decreases anxiety in patients with insomnia and anxiety.
“Significant improvement was observed in all other sleep parameters, i.e., SOL, SE, PSQI and anxiety (HAM-A scores) with Ashwagandha root extract treatment for 10 weeks.”
Human trialin patients with insomnia and anxiety300 mg twice daily10 weeksn = 58
Cureus
Ashwagandha decreases anxiety in humans.
“Recent scientific investigations into its efficacy have shown promise for relief from anxiety, insomnia and stress and for improving the immune system.”
Review
Nutrients
Ashwagandha decreases anxiety in RCTs of healthy individuals and patients with stress-related or functional disorders.
“Reported benefits included reduction of stress and anxiety, alleviation of depressive symptoms, improved sleep quality, enhancement of cognitive functions”
Reviewin RCTs of healthy individuals and patients with stress-related or functional disorders120-1000 mg daily for W. somnifera, 290-1500 mg daily for R. rosea3-16 weeks
Annals of agricultural and environmental medicine : AAEM
Ashwagandha decreases anxiety in humans.
“Ashwagandha supplementation significantly reduced anxiety (SMD: -1.55, 95% CI: -2.37, -0.74; p = .005; I2 = 93.8%)”
Reviewuntil 12,000 mg/dn = 1,002
Phytotherapy research : PTR
Muscle strength
upin humans6
6 studies
Muscle strength
upin humans6
Ashwagandha improves muscle strength in humans.
“Changes in upper and lower body muscular strength were the primary efficacy assessment of this study.”
Human trialeight-weekn = 73
F1000Research
Ashwagandha improves muscle strength in humans with resistance training (+18.2% for S500 vs. +9.7% for PLA, 95% CI: (2.4, 15.8 kg)).
“Significant group × time interaction effects were found for changes in back squat 1 RM (+18.2% for S500 vs. +9.7% for PLA, p = 0.009; 95% CI: (2.4, 15.8 kg)) and bench press 1 RM (+13.7% for S500 vs. +8.2% for PLA, p = 0.048; 95% CI: (0.03, 9.52 kg))—see and, respectively.”
Human trialwith resistance training500-mg dose12 weeksmalesn = 40
Nutrients
Ashwagandha improves muscle strength in humans (+19.1 ± 13.0 kg vs. +10.0 ± 6.2 kg (squat), +12.8 ± 8.2 kg vs. +8.0 ± 6.0 kg (bench press)).
“Gains in 1-RM squat (S500: +19.1 ± 13.0 kg vs. PLA +10.0 ± 6.2 kg, p = 0.009) and bench press (S500: +12.8 ± 8.2 kg vs. PLA: +8.0 ± 6.0 kg, p = 0.048) were significantly greater in S500.”
Human trialstandardized aqueous extract of the roots and leaves500 mg/d12 weeksmales
Nutrients
Ashwagandha improves muscle strength in humans (undergoing weight training) (Placebo: 26.42 kg vs. Ashwagandha: 46.05 kg).
“Table and Fig. show that the increases in muscle strength were statistically significantly greater in the ashwagandha group than in the placebo group, for the upper body (Placebo: 26.42 kg, 95 % CI, 19.52, 33.32 vs. Ashwagandha: 46.05 kg, 95 % CI 36.56, 55.54; p = 0.001) and the lower body (Placebo: 9.77 kg, 95 % CI, 7.18, 12.35 vs. Ashwagandha: 14.50 kg, 95 % 10.76, 18.23; p = 0.04”
Human trialundergoing weight training8 weeksmalesn = 57
Journal of the International Society of Sports Nutrition
Ashwagandha improves muscle strength in humans (engaged in resistance training) (46.0 kg (95% CI 36.6, 55.5) vs 26.4 kg (95% CI 19.5, 33.3), p = 0.001).
“Compared to the placebo subjects, the group treated with ashwagandha had significantly greater increases in muscle strength on the bench-press exercise”
Human trialengaged in resistance trainingroot extract300 mg twice daily8 weeksmalesn = 57
Journal of the International Society of Sports Nutrition
Ashwagandha improves muscle strength in humans (healthy volunteers).
“increase of strength in muscle activity was significant”
Human trialhealthy volunteersaqueous extract, 8:1750 to 1250 mg/day30 daysn = 18
Journal of Ayurveda and integrative medicine
Ashwagandha improves muscle strength in humans.
“Preliminary evidence also suggests possible improvements in strength, recovery, VO2max and body-composition parameters”
Reviewespecially when supplementation is combined with resistance training or regular physical activity
International Journal of Medical Science and Clinical Research Studies
Ashwagandha improves muscle strength in humans.
“improving crucial physiological parameters, including significant gains in muscle strength and size, enhanced cardiorespiratory fitness, hormonal balance, skin health, and improved sleep quality in older adults”
Review
Biogerontology
Quality of life
upin humans6
6 studies
Quality of life
upin humans6
Ashwagandha improves quality of life in humans (postmenopausal women).
“Quality of life improved significantly across multiple domains.”
Human trialpostmenopausal womenroot extract600 mg/day12 weeksfemalesn = 66
Menopause (New York, N.Y.)
Ashwagandha improves quality of life in humans (+9.38 vs +2.54 points).
“Similarly, quality of life, measured by SF-12, increased by 9.38 points with ARE compared with 2.54 points with the PL group (P < 0.001).”
Human trial24 weeksn = 91
Journal of medicine and life
Ashwagandha improves quality of life in humans (P < 0.05).
“Compared with PL, ARE showed significant improvements (P < 0.05) in PSS, SF-12, SSS, and FCQ-T scores.”
Human trialroot extract300 mg twice daily24 weeks
Journal of medicine and life
Ashwagandha improves quality of life in humans (FAST frailty score ≥7; assessed by SF-12; compared with placebo).
“Significant improvement (p<0.01) in scores for FAST, 6MWTs, PSQI, MMSE, and SF-12 were seen with ARE after 8 weeks.”
Human trialFAST frailty score ≥7; assessed by SF-12; compared with placeboroot extract capsule600 mg/day8 weeksn = 50
medRxivPreprint
Ashwagandha improves quality of life in humans (physical (p < 0.001), psychological (p < 0.001), environment (p < 0.01)).
“In the ashwagandha group quality of life (QOL) scores showed significant improvement in physical (p < 0.001), psychological (p < 0.001), and environment domains (p < 0.01).”
Human trialstandardized ashwagandha extract (Shoden®)120 mgsix weeksn = 144
Sleep medicine
Ashwagandha improves quality of life in humans.
“Six of the 7 studies showed significant improvement in menopausal symptoms and quality of life with the use of Ashwagandha (Withania somnifera)”
Review
Clinical Effectiveness of Ashwagandha in Menopause: A Systematic Review
Bali Medical and Wellness Journal
Ashwagandha improves quality of life in humans.
“Withania somnifera, commonly known as ashwagandha, appears to be a valuable element for improving overall quality of life due to its abundance of active substances”
Review
Ashwagandha (Withania somnifera) and Its Effects on Well-Being-A Review
Nutrients
Perceived stress
downin humans3no changein humans2
5 studies
Perceived stress
downin humans3no changein humans2
Ashwagandha decreases perceived stress in humans.
“At the end of the study, the two IP groups demonstrated a mean reduction in PSS scores almost twice that of the placebo.”
Human trial60 daysn = 186
Trials
Ashwagandha decreases perceived stress in humans (p < 0.0001).
“At day 60, both VL-G-A57 and VL-G-E12 significantly reduced Perceived Stress Scale (PSS) scores compared to placebo (p < 0.0001).”
Human trial60 days
Trials
Ashwagandha decreases perceived stress in humans (-6.16 vs -1.43).
“The PSS-10 scores showed a mean reduction of -6.16 at week 24 in the ARE group, compared with -1.43 in the PL group (P < 0.001).”
Human trial24 weeksn = 91
Journal of medicine and life
Ashwagandha decreases perceived stress in humans (P < 0.05).
“Compared with PL, ARE showed significant improvements (P < 0.05) in PSS, SF-12, SSS, and FCQ-T scores.”
Human trialroot extract300 mg twice daily24 weeks
Journal of medicine and life
Ashwagandha showed no clear effect on perceived stress in humans.
“As demonstrated in, based on the GLMM, there was no statistically significant time × group interaction in PSS total score over time (F3,439 = 0.24, p = 0.867).”
Human trial12-weekn = 120
Journal of psychopharmacology (Oxford, England)
Ashwagandha showed no clear effect on perceived stress in humans (high stress and fatigue) (p = 0.867).
“improvements were not significantly different to the placebo group (p = 0.867)”
Human trialhigh stress and fatiguestandardized root extract (Witholytin®)200 mg twice daily12-week
Journal of psychopharmacology (Oxford, England)
Ashwagandha decreases perceived stress in humans.
“The strongest human evidence supports modest benefits on perceived stress, anxiety and selected sleep outcomes.”
Review
International Journal of Medical Science and Clinical Research Studies
Ashwagandha showed no clear effect on perceived stress in meta-analysis of randomized controlled trials (SMD = -0.355, 95% CI: -1.188 to 0.47; P = 0.40).
“No significant impact was observed on perceived stress (SMD = -0.355, 95% CI: -1.188 to 0.47; P = 0.40).”
Reviewin meta-analysis of randomized controlled trialsn = 488
Nutrition and health
Testosterone
upin humans4no changein humans1+15%
5 studies
Testosterone
upin humans4no changein humans1+15%
Ashwagandha showed no clear effect on testosterone in humans (perimenopause).
“There was no significant between the group differences in the serum testosterone level.”
Human trialperimenopauseserum300 mg twice daily8-weekfemalesn = 91
The journal of obstetrics and gynaecology research
Ashwagandha increases testosterone in humans (+14.7%).
“The 2 × 2 crossover, two-sample t-test confirmed significantly higher levels of DHEA-S (T37 = 2.97, p =.005) and testosterone (T36 = 2.74, p =.010) during ashwagandha intake, compared to placebo intake (18.0% and 14.7%, respectively).”
Human trial16 weeks
American journal of men's health
Ashwagandha increases testosterone in humans (overweight males with mild fatigue) (14.7% greater increase, p = .010).
“14.7% greater increase in testosterone ( p = .010) compared to the placebo”
Human trialoverweight males with mild fatigueShoden beadssaliva21 mg of withanolide glycosides a day8 weeksmalesn = 50
American journal of men's health
Ashwagandha increases testosterone in humans (undergoing weight training) (Placebo: 18.00 ng/dL vs. Ashwagandha: 96.19 ng/dL).
“The increase in testosterone level was significantly greater with ashwagandha supplementation than with the placebo (Placebo: 18.00 ng/dL, 95 % CI, -15.83, 51.82 vs. Ashwagandha: 96.19 ng/dL, 95 % CI, 54.86, 137.53; p = 0.004).”
Human trialundergoing weight training8 weeksmalesn = 57
Journal of the International Society of Sports Nutrition
Ashwagandha increases testosterone in humans (engaged in resistance training) (96.2 ng/dL (95% CI 54.7, 137.5) vs 18.0 ng/dL (95% CI -15.8, 51.8), p = 0.004).
“significantly greater increase in testosterone level (Placebo: 18.0 ng/dL, 95% CI, -15.8, 51.8 vs. Ashwagandha: 96.2 ng/dL, 95% CI, 54.7, 137.5; p = 0.004)”
Human trialengaged in resistance trainingroot extract300 mg twice daily8 weeksmalesn = 57
Journal of the International Society of Sports Nutrition
Ashwagandha increases testosterone in humans.
“adaptogenic herbs, particularly ashwagandha, support testosterone levels by modulating cortisol and promoting testicular health”
Reviewmales
Cureus
Ashwagandha increases testosterone in humans.
“notably increasing testosterone levels in men”
Reviewmales
Evaluation of Potential Hormonal Activities of Ashwagandha (Withania somnifera)
Phytotherapy research : PTR
STRESS
downin humans5
5 studies
STRESS
downin humans5
Ashwagandha decreases stress in humans (-11.75 (SD 8.52)).
“After 8 weeks, the APB group showed significant improvements as compared to both ARE and PL groups, with mean reductions of -11.75 (SD 8.52) for PSS and -17.48 (SD 10.19) for HAM-A.”
Human trial8 weeksn = 130
Journal of medicine and life
Ashwagandha decreases stress in humans (healthy adults with moderate stress and anxiety) (P < 0.05).
“APB showed significant differences compared with ARE and PL for PSS, HAM-A total score, OHQ, and POMS (P < 0.05).”
Human trialhealthy adults with moderate stress and anxiety300 mg twice daily8 weeksn = 141
Journal of medicine and life
Ashwagandha decreases stress in humans (− 7.4 ± 0.3 for ZEN vs. 0.8 ± 0.4 for placebo, p < 0.05).
“The between-group analysis demonstrated a statistically significant (p < 0.05) decrease in PSS score in the ZEN group compared to the placebo group on days 28 (− 4.0 ± 0.3 for ZEN vs. − 1.5 ± 0.4 for placebo), 56 (− 5.9 ± 0.3 for ZEN vs. − 0.8 ± 0.4 for placebo) and 84 (− 7.4 ± 0.3 for ZEN vs. 0.8 ± 0.4 for placebo”
Human trial84 daysn = 90
Advances in therapy
Ashwagandha decreases stress in human subjects with non-chronic mild to moderate stress.
“ZEN 125 mg showed significant (p < 0.05) improvements in PSS, BAI, and PSQI scores on days 28, 56, and 84”
Human trialin human subjects with non-chronic mild to moderate stress125 mg84 days
Advances in therapy
Ashwagandha decreases stress in humans (stressed subjects) (13.0 ± 5.0 vs. 18.7 ± 4.6; p < .0001).
“At visit 4, lower PSS-10 score (13.0 ± 5.0 vs. 18.7 ± 4.6; p < .0001), serum cortisol levels (p=0.0443), and Pittsburgh Sleep Quality Index (PSQI) score (p < .0001) but higher Oxford Happiness Questionnaire (OHQ) scores (p < .0001) were seen in Ashwagandha SR vs. the placebo group”
Human trialstressed subjectssustained-release capsule300 mg90 daysn = 125
Evidence-based complementary and alternative medicine : eCAM
Ashwagandha decreases stress in humans under chronic stress.
“The treatment with Ashwagandha resulted in significant improvements in primary and secondary measures.”
Human trialunder chronic stressstandardized root extract300 mg twice daily8 weeksn = 52
Journal of evidence-based complementary & alternative medicine
Ashwagandha decreases stress in humans.
“and stress level (SMD: -1.75; 95% CI: -2.29, -1.22; p = .005; I2 = 83.1%) compared to the placebo.”
Review300-600 mg/dn = 1,002
Phytotherapy research : PTR
Inflammation
downin reviews4downin humans1
5 studies
Inflammation
downin reviews4downin humans1
Ashwagandha decreases inflammation in humans (postmenopausal) (P < 0.0001).
“Significantly decreased levels of inflammatory and oxidative stress markers high-sensitivity C-reactive protein and malondialdehyde, and increased glutathione and nitric oxide levels (P < 0.0001) were also observed.”
Human trialpostmenopausal24 weeksfemales
Journal of menopausal medicine
Ashwagandha decreases inflammation (aging and inflammation).
“role of Withania somnifera (WS) in alleviating inflammation and aging in cells by mediating several cellular signaling pathways”
Reviewaging and inflammation
New Vistas for Withania somnifera in Signal Transduction of Inflammation and Aging
Pharmaceutical research
Ashwagandha decreases inflammation.
“the action of this plant causes a decrease in the expression of pro-inflammatory cytokines.”
Review
Nutrients
Ashwagandha decreases inflammation (inflammaging).
“Taken together, this is a synthetic review on the beneficial effects of Withania somnifera in inflammaging”
Reviewinflammaging
Emerging Vistas for the Nutraceutical Withania somnifera in Inflammaging
Pharmaceuticals (Basel, Switzerland)
Ashwagandha inhibits inflammation.
“There are also reports of anti-inflammatory, antimicrobial, cardioprotective and anti-diabetic properties.”
Review
Pharmaceutics
Oxidative stress and ROS signaling
downin reviews2downin humans1no changein humans1downin rats1
5 studies
Oxidative stress and ROS signaling
downin reviews2downin humans1no changein humans1downin rats1
Ashwagandha decreases oxidative stress and ROS signaling in humans (postmenopausal) (P < 0.0001).
“Significantly decreased levels of inflammatory and oxidative stress markers high-sensitivity C-reactive protein and malondialdehyde, and increased glutathione and nitric oxide levels (P < 0.0001) were also observed.”
Human trialpostmenopausal24 weeksfemales
Journal of menopausal medicine
Ashwagandha showed no clear effect on oxidative stress and ROS signaling in humans.
“Changes in Glutathione and the marker of lipid peroxidation malondialdehyde did not significantly change from baseline to the end of the study in both groups.”
Human trialcapsuleserum60 daysn = 50
Medicine
Ashwagandha decreases oxidative stress and ROS signaling.
“Furthermore, we elucidate the beneficial effects of Withania somnifera in oxidative stress/DNA damage, immunomodulation, COVID-19, and the microbiome.”
Review
Emerging Vistas for the Nutraceutical Withania somnifera in Inflammaging
Pharmaceuticals (Basel, Switzerland)
Ashwagandha decreases oxidative stress and ROS signaling in DM.
“W. somnifera treatment in DM significantly restored the altered levels of blood glucose (experimental data; mean difference, -196.27; 95% confidence interval [-220.96, -171.58]; p < .00001) glycosylated haemoglobin (HbA1c), insulin, lipid profile, serum and oxidative stress markers”
Reviewin DM
Phytotherapy research : PTR
Ashwagandha decreases oxidative stress and ROS signaling in rats (copper-induced).
“Withania somnifera inhibited both the lipid peroxidation and protein oxidative modification induced by copper.”
Animalscopper-inducedspinal cord
Drug metabolism and drug interactions
Body weight
downin humans2no changein humans1
3 studies
Body weight
downin humans2no changein humans1
Ashwagandha decreases body weight in humans.
“However, significantly greater reductions in body weight and BMI were observed at weeks 4, 12, and 24 (P < 0.0001) with ARE compared to PL.”
Human trial24 weeksn = 91
Journal of medicine and life
Ashwagandha decreases body weight in humans (-8.46 ± 3.86 kg vs -2.41 ± 2.07 kg).
“ARE administration resulted in a significant reduction in body weight (-8.46 ± 3.86 kg; P < 0.0001) and BMI (-3.31 ± 1.57 kg/m2; P < 0.0001) compared to the PL”
Human trialroot extract300 mg twice daily24 weeks
Journal of medicine and life
Ashwagandha showed no clear effect on body weight in humans (decrease of 0.420 kg).
“Although no differences were found between groups at the end of the study in terms of body weight, the intervention group showed a decrease of 0.420 kg compared to the control group.”
Human trial40 daysn = 43
Nutrition & metabolism
Ashwagandha showed no clear effect on body weight in humans with a monitored diet.
“Ashwagandha supplementation did not produce statistically significant changes in body weight, body mass index (BMI), or waist circumference (WC).”
Human trialwith a monitored diet500 mg daily40 days
Nutrition & metabolism
Ashwagandha decreases body weight in humans (clinical studies).
“Results of Clinical studies indicate that ashwagandha supports weight loss through reduced stress, cortisol and food cravings.”
Reviewclinical studies
Journal of the American Nutrition Association
Menopausal symptoms
downin humans3
3 studies
Menopausal symptoms
downin humans3
Ashwagandha decreases menopausal symptoms in humans (postmenopausal women) (mean change -8.1 vs. -1.2).
“menopausal symptom scores (mean change -8.1 vs. -1.2; P<0.001)”
Human trialpostmenopausal womenroot extract600 mg/day12 weeksfemalesn = 66
Menopause (New York, N.Y.)
Ashwagandha decreases menopausal symptoms in humans (postmenopausal) (P < 0.0001).
“Supplemented groups showed significant dose-dependent decrease MENQOL and RI compared with placebo (P < 0.0001).”
Human trialpostmenopausal24 weeksfemales
Journal of menopausal medicine
Ashwagandha decreases menopausal symptoms in humans.
“Six of the 7 studies showed significant improvement in menopausal symptoms and quality of life with the use of Ashwagandha (Withania somnifera)”
Review
Clinical Effectiveness of Ashwagandha in Menopause: A Systematic Review
Bali Medical and Wellness Journal
Physical function
upin humans2upin reviews1
3 studies
Physical function
upin humans2upin reviews1
Ashwagandha improves physical function in humans.
“On comparing the effects of Ashwagandha extract and placebo on variables of physical performance at day 60, it was found that the average speed and total distance were statistically higher in the ashwagandha extract group”
Human trial60 days
Cureus
Ashwagandha improves physical function.
“indicate its potential to increase muscle strength, facilitate muscle regeneration, and improve cardiorespiratory endurance.”
Review
Nutrition & metabolism
Ashwagandha improves physical function in humans.
“Ashwagandha supplementation may improve various aspects of sports performance, such as endurance and muscular strength”
Reviewn = 9,005
Muscles (Basel, Switzerland)
All 99Fewer
Has ashwagandha been tested in people?
0 of 7 about agingYes: 76 trials and 2 observational studies in people have been published, and 6 trials are registered.
In trials
Phase 2Status unknown1 trial
Craving
Phase 2Completed1 trial
Phase 2Completed1 trial
Phase 2Completed1 trial
Phase 2Completed1 trial
Sleep
Phase 2Completed1 trial
All 9Fewer
Trial sponsors
Company1 trialPhase 2120 people
1 trialPhase 280 people
Sunnybrook Health Sciences Centre
1 trialPhase 275 people
University of Colorado, Colorado Springs
1 trialPhase 260 people
Tatyasaheb Kore Dental College
1 trialPhase 1/250 people
1 trialPhase 1/224 people